CHTP - Be an interesting day tomorrow to see! FDA Advisory Panel Recommends Approval of Chelsea Therapeutics' NORTHERA(TM)(Droxidopa) for the Treatment of Symptomatic nOH
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.